HCW Biologics Inc.
HCWB
$7.05
-$0.58-7.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 368.30% | -14.04% | -71.57% | 13.60% | -67.96% |
| Total Receivables | -10.68% | -0.49% | -27.54% | -41.14% | 116.28% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.86% | -12.03% | -48.32% | -24.85% | -40.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 28.83% | -46.48% | -62.36% | 89.39% | 32.02% |
| Total Current Assets | 172.10% | -12.22% | -61.57% | -3.05% | -53.75% |
|
|
|||||
| Total Current Assets | 172.10% | -12.22% | -61.57% | -3.05% | -53.75% |
| Net Property, Plant & Equipment | 0.33% | 0.12% | 0.95% | 10.45% | 37.73% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -49.56% | -98.94% |
| Total Assets | 13.86% | -0.98% | -11.86% | 6.71% | -19.94% |
|
|
|||||
| Total Accounts Payable | -1.47% | 34.30% | 60.84% | 70.15% | 95.55% |
| Total Accrued Expenses | 5.50% | -85.03% | 112.99% | 19.99% | 30.35% |
| Short-term Debt | -0.41% | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 1.61% | -- | -- | -21.67% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -1.44% | 29.48% | 73.11% | 53.33% | 61.49% |
|
|
|||||
| Total Current Liabilities | -1.44% | 29.48% | 73.11% | 53.33% | 61.49% |
| Long-Term Debt | 14.16% | -34.72% | 19.65% | 31.25% | -0.45% |
| Short-term Debt | -0.41% | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.32% | 10.28% | 52.72% | 44.08% | 28.11% |
|
|
|||||
| Common Stock & APIC | 7.54% | 0.27% | 0.28% | 3.27% | 0.33% |
| Retained Earnings | -3.47% | -4.18% | -19.59% | -10.59% | -17.84% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.09% | -58.25% | -172.08% | -35.07% | -43.60% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.09% | -58.25% | -172.08% | -35.07% | -43.60% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.09% | -58.25% | -172.08% | -35.07% | -43.60% |
|
|
|||||